Urgent

Syphilis (staging & management)

STI / sexual health · Genitourinary
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Treponema pallidum infection, staged by time and features. PRIMARY: painless indurated chancre + regional lymphadenopathy (9–90 days after exposure). SECONDARY (weeks–months): non-itchy maculopapular rash incl. palms/soles, mucous patches, condylomata lata, fever, lymphadenopathy, patchy alopecia. LATENT (asymptomatic, serology only) — EARLY latent < 2 years, LATE latent ≥ 2 years/unknown duration. TERTIARY (years): gummata, cardiovascular (aortitis/aneurysm), late neurosyphilis. NEUROSYPHILIS can occur at ANY stage (meningitis, cranial nerve/eye — ocular syphilis, stroke, tabes dorsalis, general paresis). CONGENITAL from vertical transmission.

Red flags

  • Neurological or ocular/auditory symptoms — neurosyphilis/ocular syphilis (urgent LP + IV therapy)
  • Pregnancy — risk of congenital syphilis; treat promptly
  • Cardiovascular syphilis (aortitis/aneurysm)
  • Jarisch–Herxheimer reaction after first dose (fever, myalgia, worsening rash)

Assessment

Differential diagnosis

  • Genital herpes / chancroid / LGV (genital ulcer)
  • Other causes of maculopapular rash (drug, viral, pityriasis rosea, HIV seroconversion)
  • Behçet disease
  • Guillain–Barré / other neuropathy (neurosyphilis)
  • Aortic aneurysm of other cause

Investigations

  • Serology: treponemal test (EIA/TPPA) to confirm + non-treponemal (RPR/VDRL) titre for activity & monitoring
  • Dark-ground microscopy / PCR of chancre or lesion exudate (early)
  • Full STI screen incl. HIV, hepatitis B/C, gonorrhoea/chlamydia
  • LP for CSF (VDRL, protein, cells) if neurological/ocular signs or treatment failure
  • Pregnancy test; ophthalmology/CVS assessment if indicated

Management

  • Confirm stage clinically + serologically; assess for neuro/ocular involvement (any stage → LP + specialist)
  • EARLY syphilis (primary, secondary, early latent < 2 y): benzathine penicillin G 2.4 MU IM single dose
  • LATE latent / tertiary (non-neuro): benzathine penicillin G 2.4 MU IM once weekly for 3 doses
  • NEUROSYPHILIS / ocular / otosyphilis: IV benzylpenicillin (or IM procaine penicillin + oral probenecid) for 14 days
  • Penicillin allergy: doxycycline 100 mg PO BD (14 days early / 28 days late); consider desensitisation in pregnancy/neuro
  • Warn about the Jarisch–Herxheimer reaction; notify partners, contact-trace, and refer to GUM/sexual health; treat in pregnancy to prevent congenital syphilis

Drugs & doses

Benzathine benzylpenicillin 2.4 MU IM (early: single dose; late: weekly ×3)
Benzylpenicillin IV / procaine penicillin IM + probenecid ×14 days (neurosyphilis)
Doxycycline 100 mg PO BD (penicillin allergy)
Paracetamol ± prednisolone cover for Jarisch–Herxheimer / cardiovascular / ocular disease

Disposition

Most managed via GUM/sexual health as outpatient; admit for IV therapy if neurosyphilis, ocular syphilis, or systemically unwell.

Complications & pitfalls

  • Neurosyphilis, ocular syphilis, deafness
  • Cardiovascular syphilis (aortic aneurysm/regurgitation)
  • Gummata
  • Congenital syphilis / stillbirth
  • Facilitated HIV transmission

Exam pearls

  • Rash on the palms and soles — think secondary syphilis (or another cause) until proven otherwise
  • Neuro/ocular/otological signs at ANY stage → treat as neurosyphilis (IV penicillin), not a single IM dose
  • Non-treponemal titre (RPR/VDRL) is used to follow response — expect a four-fold fall
  • Always test for HIV and other STIs; syphilis is a notifiable public-health condition

Stage it (primary/secondary/latent/tertiary), rule out neuro-ocular disease, and treat with the stage-appropriate penicillin regimen; partner-notify and screen for co-infection.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.